Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
02 Feb 2024
Historique:
received: 26 06 2023
accepted: 02 01 2024
medline: 2 2 2024
pubmed: 2 2 2024
entrez: 2 2 2024
Statut: aheadofprint

Résumé

Onco-hematological studies are increasingly adopting statistical mixture models to support the advancement of the genomically-driven classification systems for blood cancer. Targeting enhanced patients stratification based on the sole role of molecular biology attracted much interest and contributes to bring personalized medicine closer to reality. In onco-hematology, Hierarchical Dirichlet Mixture Models (HDMM) have become one of the preferred method to cluster the genomics data, that include the presence or absence of gene mutations and cytogenetics anomalies, into components. This work unfolds the standard workflow used in onco-hematology to improve patient stratification and proposes alternative approaches to characterize the components and to assign patient to them, as they are crucial tasks usually supported by a priori clinical knowledge. We propose (a) to compute the parameters of the multinomial components of the HDMM or (b) to estimate the parameters of the HDMM components as if they were Multivariate Fisher's Non-Central Hypergeometric (MFNCH) distributions. Then, our approach to perform patients assignments to the HDMM components is designed to essentially determine for each patient its most likely component. We show on simulated data that the patients assignment using the MFNCH-based approach can be superior, if not comparable, to using the multinomial-based approach. Lastly, we illustrate on real Acute Myeloid Leukemia data how the utilization of MFNCH-based approach emerges as a good trade-off between the rigorous multinomial-based characterization of the HDMM components and the common refinement of them based on a priori clinical knowledge.

Identifiants

pubmed: 38306404
doi: 10.1371/journal.pcbi.1011299
pii: PCOMPBIOL-D-23-01010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011299

Informations de copyright

Copyright: © 2024 Dall’Olio et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Daniele Dall'Olio (D)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia.

Eric Sträng (E)

Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Amin T Turki (AT)

Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, Bochum, Germany.

Jesse M Tettero (JM)

Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands.

Martje Barbus (M)

AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany.

Javier Martinez Elicegui (JM)

Molecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca, Salamanca, Spain.

Tommaso Matteuzzi (T)

Department of Physics and Astronomy, University of Florence, Sesto Fiorentino, Italy.

Alessandra Merlotti (A)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia.
Physics and Astronomy Department, University of Bologna, Bologna, Italy.

Luciana Carota (L)

Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.

Claudia Sala (C)

Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.

Matteo G Della Porta (MG)

Comprehensive Cancer Center, IRCCS Humanitas Clinical and Research Center and Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Enrico Giampieri (E)

Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.

Jesús María Hernández-Rivas (JM)

Molecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca, Salamanca, Spain.
Hematology Department, University Hospital of Salamanca, Salamanca, Spain.
Cancer Research Center of Salamanca, Salamanca, Spain.

Lars Bullinger (L)

Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Gastone Castellani (G)

Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.

Classifications MeSH